Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 10:35 AM ET 5/23/2013
Last 10 Quotes:
What's This?
Competitive Analysis
Competitive Analysis (cont.)
| AstraZeneca PLC ADS | Dr. Reddy's Laboratories Ltd. ADS | Astrazeneca PLC | Shire PLC ADS | Sanofi | |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| Current Share Price | 51.72 | 37.21 | 51.40 | 96.32 | 108.65 |
| Market Value | $65,615 mil | $6,284 mil | $65,615 mil | $17,963 mil | $144,108 mil |
| Revenues | $17,653 mil | $97,086 mil | $17,653 mil | $2,954 mil | $34,947 mil |
| Net Earnings | $3,993 mil | $13,009 mil | $3,993 mil | $470 mil | $5,136 mil |
| 5-yr Sales Growth | 0.48% | 18.90% | 0.48% | 15.84% | 5.35% |
| 5-yr Earnings Growth | 7.45% | 38.99% | 7.45% | 85.87% | 5.43% |
| Net Profit Margin | 20.96% | 12.06% | 20.96% | 12.24% | 12.01% |
| Short Interest | 1.60 | 3.45 | NA | 1.04 | NA |
| Proj. Long-Term EPS Growth (%) | -7.30% | NA | -5.85% | 12.92% | 5.46% |
| Forward P/E | 9.84 | 18.71 | 9.84 | 14.52 | 14.73 |
| PEG | NA | 1.09 | NA | 1.36 | 1.84 |
| Price/Sales | 2.55 | 3.00 | 2.55 | 4.02 | 3.31 |
| Price/Cash Flow | 18.26 | NA | 18.26 | 17.29 | NA |
| Price/Book | 2.48 | 5.98 | 2.48 | 4.53 | 1.65 |
| ROE | 25.43% | 27.01% | 25.43% | 15.41% | 7.30% |
| ROA | 10.90% | 13.03% | 10.90% | 7.97% | 4.10% |
| Dividends | $1.90 | $0.25 | $1.93 | $0.44 | $3.59 |
| Dividend Yield | 7.35% | 0.67% | 7.50% | 0.91% | 3.31% |
| Payout Ratio | 56.71% | 17.91% | 56.71% | 13.14% | 73.67% |
| Total Return (12-mos) | 27.13% | 25.01% | 25.05% | 10.00% | 57.51% |
| Total Return (3-yr) | 32.80% | 34.33% | 23.01% | 60.36% | 88.98% |
| Beta | 0.61 | 0.09 | 0.61 | 0.63 | 0.10 |
| % Off 52-wk High | 1.90% | 3.95% | 2.00% | 5.61% | 4.57% |
| % Above 52-wk Low | 30.21% | 36.40% | 28.98% | 20.26% | 59.66% |
| Consensus Analyst Recommendation | Hold | Overweight | Hold | Overweight | Overweight |
